CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 20.671
AS - Asia 9.059
EU - Europa 6.826
SA - Sud America 1.739
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 13
Totale 38.547
Nazione #
US - Stati Uniti d'America 20.387
SG - Singapore 4.340
CN - Cina 1.854
UA - Ucraina 1.849
BR - Brasile 1.370
IT - Italia 1.135
DE - Germania 1.106
HK - Hong Kong 967
FI - Finlandia 801
VN - Vietnam 594
RU - Federazione Russa 484
FR - Francia 381
IE - Irlanda 313
IN - India 245
TR - Turchia 236
SE - Svezia 214
GB - Regno Unito 186
CA - Canada 166
AR - Argentina 150
BD - Bangladesh 139
KR - Corea 138
IQ - Iraq 83
MX - Messico 70
JP - Giappone 67
PK - Pakistan 64
NL - Olanda 59
ZA - Sudafrica 59
BE - Belgio 53
ID - Indonesia 51
CO - Colombia 50
EC - Ecuador 49
AT - Austria 48
PL - Polonia 44
ES - Italia 40
SA - Arabia Saudita 36
UZ - Uzbekistan 36
VE - Venezuela 34
MA - Marocco 30
CZ - Repubblica Ceca 27
CL - Cile 23
JO - Giordania 22
EU - Europa 21
EG - Egitto 20
MY - Malesia 20
PY - Paraguay 19
PE - Perù 18
IR - Iran 17
KE - Kenya 16
LB - Libano 16
TN - Tunisia 16
PH - Filippine 15
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AU - Australia 12
CR - Costa Rica 11
DZ - Algeria 11
IL - Israele 11
OM - Oman 11
AZ - Azerbaigian 10
ET - Etiopia 10
RS - Serbia 10
BO - Bolivia 9
KZ - Kazakistan 9
TG - Togo 9
CH - Svizzera 8
JM - Giamaica 8
XK - ???statistics.table.value.countryCode.XK??? 8
LT - Lituania 7
TW - Taiwan 7
AL - Albania 6
EE - Estonia 6
PS - Palestinian Territory 6
RO - Romania 6
SN - Senegal 6
AM - Armenia 5
DO - Repubblica Dominicana 5
KH - Cambogia 5
PA - Panama 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BW - Botswana 4
DK - Danimarca 4
GR - Grecia 4
KG - Kirghizistan 4
RE - Reunion 4
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
MU - Mauritius 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BT - Bhutan 2
Totale 38.489
Città #
Woodbridge 2.091
Singapore 1.870
Fairfield 1.829
Ashburn 1.515
Ann Arbor 1.475
Jacksonville 1.307
Houston 1.128
Chandler 975
Hong Kong 961
San Jose 899
Beijing 858
Dearborn 788
Wilmington 783
Seattle 725
Cambridge 648
Boardman 455
Council Bluffs 342
Princeton 336
Dublin 311
Lauterbourg 309
Munich 270
Los Angeles 234
Helsinki 205
Buffalo 183
Udine 183
Izmir 163
Hefei 150
Ho Chi Minh City 148
Dallas 145
San Diego 129
New York 126
Hanoi 125
Seoul 124
São Paulo 108
Redondo Beach 96
Milan 89
The Dalles 88
Santa Clara 85
Ottawa 79
Des Moines 78
Pittsburgh 76
Ogden 71
Orem 68
Norwalk 65
Tokyo 58
Dong Ket 53
Frankfurt am Main 53
Nanjing 51
Mumbai 50
Kunming 49
Rome 48
Redmond 47
Rio de Janeiro 45
San Mateo 45
Warsaw 43
Guangzhou 42
Brooklyn 40
Brussels 40
Nuremberg 39
Atlanta 38
Baghdad 34
Belo Horizonte 33
Johannesburg 33
Chennai 31
Denver 31
London 31
Manchester 31
Tashkent 31
Amsterdam 30
Chicago 30
Phoenix 30
Stockholm 30
Brasília 29
Montreal 29
Boston 27
Shanghai 27
Vienna 26
Grafing 25
Da Nang 24
Falls Church 24
Trieste 24
Dhaka 23
Haiphong 23
Brno 22
Mexico City 22
San Francisco 22
Turku 22
Ankara 21
Düsseldorf 20
Jinan 20
New Delhi 20
Toronto 20
Washington 20
Amman 18
Goiânia 18
Lahore 18
Porto Alegre 18
Paris 17
Hyderabad 16
Poplar 16
Totale 24.420
Nome #
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 279
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 270
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 249
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 243
Abnormalities of insulin receptors in spontaneously hypertensive rats 207
Aldosterone and the heart: from basic research to clinical evidence 206
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 199
Aldosterone and Left Ventricular Remodeling 198
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 191
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 184
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 182
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 181
Abnormalities of glucose metabolism in patients with early renal failure 180
Aldosterone and the heart: still an unresolved issue? 180
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 178
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 175
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 174
Aldosterone, Organ Damage, and Dietary Salt 173
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 172
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 171
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 171
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 169
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 166
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 166
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 166
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 165
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 162
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 162
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 161
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 160
Diabetes, diabetic complications, and blood pressure targets 160
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 160
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 159
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 159
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 158
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 157
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 157
Treatment of primary aldosteronism and organ protection 157
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 156
Prohypertensive effect of insulin: possible role of the sympathetic system 155
The emergent cardiovascular risk factors and organ damage in arterial hypertension 155
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 155
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 155
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 153
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 151
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 151
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 150
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 149
Salt, hypertension, and cardiovascular disease 149
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 149
Cardiovascular outcomes in patients with primary aldosteronism after treatment 149
Spontaneous restoration of sinus rhythm after cardiac surgery 149
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 147
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 145
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 145
Benzodiazepines: an old class of new antihypertensive drugs? 145
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 144
Renal function in primary aldosteronism 143
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 143
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 143
The SPARTACUS Trial: Controversies and Unresolved Issues 143
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 143
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 143
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 143
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 141
Potassium-sparing diuretics in hypertension 141
Kidney in primary aldosteronism: a key determinant of treatment outcome 141
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 140
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 140
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 139
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 138
Glucose metabolism in early renal failure 138
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 138
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 138
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 136
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 136
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 135
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 134
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 134
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 134
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 134
Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension 132
Effects of zofenopril, carvedilol, and lacidipine on alcohol-induced responses in cultured human endothelial cells 132
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 132
Benign familial macrocytosis 132
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 132
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 132
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 132
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 131
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 130
Hypertension and abnormalities of carbohydrate metabolism: possible role of sympathetic nervous system 129
Endothelial function in patients with non-alcoholic fatty liver disease 129
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 129
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 129
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 129
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 128
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 127
Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage 127
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 127
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 127
Totale 15.563
Categoria #
all - tutte 150.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 0 0 0 0 0 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/202611.145 783 1.138 906 1.015 1.668 901 1.490 377 907 1.043 731 186
Totale 39.425